FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310853652> ?p ?o ?g. }

• W4310853652 endingPage "72" @default.
• W4310853652 startingPage "70" @default.
• W4310853652 abstract "Tuberculosis being the foremost opportunistic infection associated with Human Immunodeciency Virus infection contributes to high morbidity and mortality among HIV seropositive persons. As per World Health Organisation TB statistics for 2020, and the India TB Report 2021- The incidence of TB cases including HIV in India was 193 per 100000 population, of which mortality was 32 per 100000 cases. Isoniazid Preventive Therapy reduces the reactivation of latent Tuberculosis infection and reduces the risk of acquiring TB by 70-90% among HIV co-infected individuals. WHO recommends use of ART and Isoniazid Preventive Therapy (IPT) combination to reduce the burden of TB among HIV infected patients. Considering the benets of IPT in PLHIV patients, this study was conducted over a period of 2 years from January 2020 to December 2021 in patients attending ART OPD of a tertiary care hospital in southern Maharashtra. Methods A prospective observational study was conducted on patients attending ART OPD along with General Medicine OPD at a tertiary care hospital from January 2020 to December 2021. A total of 1497 PLHIV patients were started on IPT during this period and followed up. Results 92.18% i.e. 1380 of 1497 patients completed 6 months of IPT with remaining 7.82% i.e. 117 patients not able to complete the entire 6 months due to treatment related side effects, follow up difculties or mortality. Of 1497 patients, only 2 patients (0.13%) developed Pulmonary Tuberculosis after initiation of IPT and the remaining didn't show any signs or symptoms of tuberculosis on follow up. Conclusion Results of IPT in PLHIV were highly effective with only 0.13% i.e. 2 patients developing Tuberculosis during the course of treatment with the remaining not having tuberculosis even on follow up or being reported till date. The results of the study along with other studies conducted worldwide clearly indicate the effectiveness of IPT in PLHIV and thereby its implementation should be further strengthened." @default.
• W4310853652 created "2022-12-19" @default.
• W4310853652 creator A5016171430 @default.
• W4310853652 creator A5062893713 @default.
• W4310853652 date "2022-11-01" @default.
• W4310853652 modified "2023-10-18" @default.
• W4310853652 title "EFFECTIVENESS OF ISONIAZID PREVENTIVE THERAPY ON INCIDENCE OF TUBERCULOSIS AMONG PEOPLE LIVING WITH HIV IN SOUTHERN MAHARASHTRA" @default.
• W4310853652 cites W1868297963 @default.
• W4310853652 cites W1920771564 @default.
• W4310853652 cites W1980300049 @default.
• W4310853652 cites W1986207517 @default.
• W4310853652 cites W2004105235 @default.
• W4310853652 cites W2082349840 @default.
• W4310853652 cites W2128620327 @default.
• W4310853652 cites W2133015966 @default.
• W4310853652 cites W2146216814 @default.
• W4310853652 cites W2148397464 @default.
• W4310853652 cites W2149492547 @default.
• W4310853652 cites W2166653928 @default.
• W4310853652 doi "https://doi.org/10.36106/ijsr/7208256" @default.
• W4310853652 hasPublicationYear "2022" @default.
• W4310853652 type Work @default.
• W4310853652 citedByCount "0" @default.
• W4310853652 crossrefType "journal-article" @default.
• W4310853652 hasAuthorship W4310853652A5016171430 @default.
• W4310853652 hasAuthorship W4310853652A5062893713 @default.
• W4310853652 hasConcept C120665830 @default.
• W4310853652 hasConcept C121332964 @default.
• W4310853652 hasConcept C126322002 @default.
• W4310853652 hasConcept C142724271 @default.
• W4310853652 hasConcept C187212893 @default.
• W4310853652 hasConcept C188816634 @default.
• W4310853652 hasConcept C23131810 @default.
• W4310853652 hasConcept C2776967927 @default.
• W4310853652 hasConcept C2781069245 @default.
• W4310853652 hasConcept C2908647359 @default.
• W4310853652 hasConcept C61511704 @default.
• W4310853652 hasConcept C71924100 @default.
• W4310853652 hasConcept C99454951 @default.
• W4310853652 hasConceptScore W4310853652C120665830 @default.
• W4310853652 hasConceptScore W4310853652C121332964 @default.
• W4310853652 hasConceptScore W4310853652C126322002 @default.
• W4310853652 hasConceptScore W4310853652C142724271 @default.
• W4310853652 hasConceptScore W4310853652C187212893 @default.
• W4310853652 hasConceptScore W4310853652C188816634 @default.
• W4310853652 hasConceptScore W4310853652C23131810 @default.
• W4310853652 hasConceptScore W4310853652C2776967927 @default.
• W4310853652 hasConceptScore W4310853652C2781069245 @default.
• W4310853652 hasConceptScore W4310853652C2908647359 @default.
• W4310853652 hasConceptScore W4310853652C61511704 @default.
• W4310853652 hasConceptScore W4310853652C71924100 @default.
• W4310853652 hasConceptScore W4310853652C99454951 @default.
• W4310853652 hasLocation W43108536521 @default.
• W4310853652 hasOpenAccess W4310853652 @default.
• W4310853652 hasPrimaryLocation W43108536521 @default.
• W4310853652 hasRelatedWork W11079011 @default.
• W4310853652 hasRelatedWork W2004174010 @default.
• W4310853652 hasRelatedWork W2029812690 @default.
• W4310853652 hasRelatedWork W2322944276 @default.
• W4310853652 hasRelatedWork W2916582253 @default.
• W4310853652 hasRelatedWork W2952622458 @default.
• W4310853652 hasRelatedWork W4205432698 @default.
• W4310853652 hasRelatedWork W4241340989 @default.
• W4310853652 hasRelatedWork W4293059806 @default.
• W4310853652 hasRelatedWork W4296044745 @default.
• W4310853652 isParatext "false" @default.
• W4310853652 isRetracted "false" @default.
• W4310853652 workType "article" @default.